Recent News

• 02.04.2025 - Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
• 01.23.2025 - Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
• 01.14.2025 - Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
• 01.06.2025 - Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Recent Filings

• 02.04.2025 - 8-K Current report
• 01.28.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.27.2024 - 4 Statement of changes in beneficial ownership of securities